IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease

Journal of Clinical Immunology

Volumn 20, Issue 5, 2000, Pages 362-370

  Gasche, Christoph ^a   Bakos, Silvia ^a   Dejaco, Clemens ^a   Tillinger, Wolfgang ^a   Zakeri, Schaker ^a   Reinisch, Walter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Inflammatory bowel disease; Interleukin 10; Lamina propria mononuclear cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; INTESTINE; KNOCKOUT MOUSE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SUPERNATANT; ULCERATIVE COLITIS;

ADULT; AGED; CELLS, CULTURED; COLITIS, ULCERATIVE; COLONOSCOPY; COMPARATIVE STUDY; CROHN DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERLEUKIN-10; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0033782650     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006672114184     Document Type: Article

References (60)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis
3. Mycobacterium paratuberculosis DNA in Crohn's disease tissue
4. The role of perinatal measles infection in the aetiology of Crohn's disease: A population-based epidemiological study
5. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease
6. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
7. Interleukin-10
8. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monozytes
9. IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
10. IL-10 inhibits cytokine production by activated macrophages
11. IL-10 and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
12. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells
13. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells
14. Interleukin-10-deficient mice develop chronic enterocolitis
15. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
16. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group
17. Safety, tolerance and activity of multiple doses of subcutaneous recombinant human interleukin-10 (rHuIL-10) in patients with mild to moderate active Crohn's disease
18. A safety and efficacy study of recombinant human interleukin-10 (rHulL-10) treatment in 329 patients with chronic active Crohn's disease (CACD)
19. Two-stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
20. Mapping of a susceptibilty locus for Crohn's disease on chromosome 16
21. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis
22. Linkage and association between inflammatory bowel disease and a locus on chromosome 12
23. Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis
24. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and 1BD1
25. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6
26. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis
27. Novel genetic association between ulcerative colitis and anti-inflammatory cytokine interleukin-1 receptor antagonist
28. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease
29. An investigation of polymorphism in the interleukin-10 gene promoter
30. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility
31. Molecular analysis of the IL-10 coding sequence and protein expression in Crohn's disease patients with different clinical response to rhIL-10
32. A polymorphic dinucleotide repeat in the human IL-10 promoter
33. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence
34. Expression, cloning and characterization of a human IL-10 receptor
35. Development of a Crohn's disease activity index
36. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
37. A simple classification of Crohn's disease
38. Viewpoints on digestive diseases and cytokines in the intestinal inflammation: Pathophysiological and clinical considerations
39. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD)
40. Involvement of interleukin-4 and-10 in inflammatory bowel disease
41. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus
42. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease
43. Cytokine production in patients with inflammatory bowel disease
44. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease
45. Influence of topically and systemically active steroids on circulating leucocytes in Crohn's disease
46. Genetic influence on cytokine production and fatal meningococcal disease
47. Interleukin 10 secretion in relation to human IL-10 locus haplotypes
48. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)
49. Inflammatory bowel disease mucosal biopsies have specialized lymphokine mRNA profiles
50. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease
51. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease
52. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa
53. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease
54. Interferon gamma inhibits interleukin 10 production by monocytes
55. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes
56. IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease
57. Diminished sensitivity of ileal lamina propria mononuclear cells to the inhibitory effect of IL-10 in Crohn's disease
58. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
59. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action
60. A Janus kinase inhibitor JAB, is an interferon-gamma-inducible gene and confers resistance to interferons